[1]陈 娜,杨军辉,刘 玲.补肺化瘀通络汤联合阿替普酶治疗慢性肺栓塞疗效研究[J].陕西中医,2021,(12):1688-1691.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.008]
　CHEN Na,YANG Junhui,LIU Ling.Study on effect of Bufei Huayu Tongluo decoction combined with alteplase in the treatment of chronic pulmonary embolism[J].,2021,(12):1688-1691.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.008]
点击复制

补肺化瘀通络汤联合阿替普酶治疗慢性肺栓塞疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年12期
页码:
1688-1691
栏目:
临床研究
出版日期:
2021-12-05

文章信息/Info

Title:
Study on effect of Bufei Huayu Tongluo decoction combined with alteplase in the treatment of chronic pulmonary embolism
作者:
陈 娜; 杨军辉; 刘 玲
(华中科技大学同济医学院附属武汉市中心医院,湖北 武汉 430014)
Author(s):
CHEN Na; YANG Junhui; LIU Ling
(Wuhan Central Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430014,China)
关键词:
慢性肺栓塞;  补肺化瘀通络汤;  阿替普酶;  D-二聚体;  血清高迁移率族蛋白B1
Keywords:
Chronic pulmonary embolism;  Bufei Huayu Tongluo decoction;  Artipase;  D-dimer;  Serum high mobility group protein B1
分类号:
R 563.5
DOI:
DOI:10.3969/j.issn.1000-7369.2020.12.008
文献标志码:
A
摘要:
目的:分析补肺化瘀通络汤联合阿替普酶治疗慢性肺栓塞疗效及对患者血浆D-二聚体(D-D)、肌钙蛋白(cTnI)、血清高迁移率族蛋白B1(HMGB-1)的影响。方法:将90例慢性肺栓塞患者以随机数字表法分为两组,每组45例。对照组予阿替普酶治疗,治疗组予补肺化瘀通络汤联合阿替普酶治疗。对比两组疗效及肺功能、血气指标、凝血功能及D-D、cTnI、HMGB-1水平。结果:治疗组总有效率为97.78%,高于对照组的77.78%(P<0.05)。治疗后治疗组FIB水平高于对照组,PT、TT、APTT水平低于对照组,差异有统计学意义(均P<0.05)。治疗后治疗组FEV1/FVC、FEV1高于对照组,治疗组D-D、cTnI、HMGB-1水平低于对照组,差异有统计学意义(均P<0.05)。治疗后治疗组PaCO2低于对照组,PaO2高于对照组,差异有统计学意义(均P<0.05)。结论:补肺化瘀通络汤联合阿替普酶治疗慢性肺栓塞疗效较好,可提高患者肺功能,改善凝血功能、血气指标,降低D-D、cTnI、HMGB-1水平。
Abstract:
Objective:To analyze efficacy of Bufei Huayu Tongluo decoction combined with alteplase in the treatment of chronic pulmonary embolism and its effects on plasma D-dimer(D-D),cardiac troponin I(cTnI)and serum high mobility group protein B1(HMGB-1).Methods:90 patients were divided into two groups according to random number table method,45 cases in each group.The control group received alteplase treatment,and the treatment group received Bufei Huayu Tongluo decoction combined with alteplase treatment.Efficacy and lung function,blood gas index,coagulation function and D-D,cTnI,HMGB-1 were compared between the two groups.Results:The total effective rate of the treatment group was 97.78% higher than 77.78% of the control group(P<0.05).After treatment,the level of FIB in the treatment group was higher than that in the control group,while the levels of PT,TT,APTT were lower than those in the control group,difference statistically significant(all P<0.05).After treatment,the levels of FEV1/FVC,FEV1 in the treatment group were higher than those in the control group,and the levels of D-D,cTnI,HMGB-1 in the treatment group were lower than those in the control group,difference statistically significant(all P<0.05).After treatment,the level of PaCO2 in the treatment group was lower than that in the control group,while the level of PaO2 was higher than that in the control group,difference statistically significant(all P<0.05).Conclusion:Bufei Huayu Tongluo decoction combined with alteplase has good effect in the treatment of chronic pulmonary embolism,which can improve lung function,coagulation function,blood gas index,and reduce D-D,cTnI,HMGB-1 levels.

参考文献/References:

[1] 张丹妮,胡良安.慢性阻塞性肺疾病与肺栓塞研究进展[J].临床肺科杂志,2015,20(1):142-144.
[2] 许明玲,程兆忠,王丽君,等.经抗凝治疗的非高危肺栓塞患者远期预后分析[J].国际呼吸杂志,2017,37(4):276-280.
[3] Lnde YM,Cannegieter SC,Vonk NA,et al.Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism:A contemporary view of the published literature[J].Eur Respir Journal,2017,49(2):792.
[4] 陈秀梅,卢新政.2008年欧洲肺栓塞诊断治疗指南解读[J].心血管病学进展,2009,30(3):361-364.
[5] 钱蓓蓓,张静华,陶佳莹,等.血浆 FIB 及 D-二聚体在肺栓塞治疗中的临床意义[J].检验医学与临床,2017,14(10):1377-1378.
[6] 郎达民,周景明,马靖华.胸外科术后肺栓塞诊断中的D-二聚体检测及其临床分析[J].陕西医学杂志,2015,46(12):1611,1613.
[7] 陈振华,丘新才,林淑芳,等.阿替普酶联合华法林治疗慢性阻塞性肺疾病合并肺栓塞的效果观察[J].山东医药,2016,56(28):93-95.
[8] 胡欣妍.桃红四物汤对急性肺栓塞发展为慢性血栓栓塞性肺动脉高压症的干预作用[J].中国中医药科技,2017,24(4):525-527.
[9] 金婷婷,朱紧超,张兴彩.中西医结合治疗慢性血栓栓塞性肺动脉高压病验案1则[J].湖南中医杂志,2017,33(8):112-113.
[10] 于蓓蓓,闫雪生,孙丹丹.山楂药理作用及其机制研究进展[J].中南药学,2015,13(7):745-748.
[11] 王永奇,邢福有,刘凡亮,等.紫苏子镇咳、祛痰、平喘作用的药理研究[J].中国实用医药,2015,1(10):135-138.
[12] 马丙祥,董宠凯.丹参的药理作用研究新进展[J].中国药房,2014,25(7):663-665.
[13] 王渝蓉,徐晓容.活血化瘀通络汤对急性脑梗死合并心力衰竭患者的疗效评价[J].中国医药指南,2016,14(9):221-222.
[14] 肖云艳.补肺化瘀通络汤治疗慢性肺栓塞的临床疗效观察[J].陕西中医,2016,37(1):44-45.
[15] 林巧红,杨继松,刘庆标.祛风活血通络汤中药封包对慢性损伤性疾病的功能康复的影响分析[J].中国医药科学,2016,6(13):66-68.
[16] 郭文慧,原 景,张 炜.益气活血化痰方治疗慢性阻塞性肺疾病稳定期疗效研究[J].陕西中医,2021,42(6):721-723,738.
[17] 刘 佳,杨 英.补肺化瘀通络汤联合瑞替普酶对肺栓塞患者肺通气功能及血清Xa因子水平的影响[J].临床医学研究与实践,2021,6(5):150-152.
[18] 陈 英,王 娅.补肺活血化瘀法对COPD患者血清NO水平、血液流变学及生活质量的影响[J].西部中医药,2020,33(5):91-94.
[19] 刘 佳,杨 英. 补肺化瘀通络汤联合瑞替普酶对肺栓塞患者肺通气功能及血清χa因子水平的影响[J].临床医学研究与实践,2021,6(5):150-152.
[20] 李嘉鑫,张浩跃,李 涵. 补肺化瘀通络汤联合阿替普酶治疗慢性肺栓塞疗效及对血清高迁移率族蛋白B1、肌钙蛋白和血浆D-二聚体的影响[J].现代中西医结合杂志,2019,28(22):2467-2469,2477.
[21] 张守军,徐宝清,周 芬.补肺化瘀通络汤治疗慢性肺栓塞疗效及对呼吸功能和血氧饱和度水平的影响[J].中华中医药学刊,2019,37(11):2802-2805.
[22] 于鸿敏,乔 华,张向宁,等.阿哌沙班联合瑞替普酶对急性肺栓塞患者凝血功能与安全性影响[J].中国煤炭工业医学杂志,2021,24(4):381-386.
[23] 赵新春,张 翔.利伐沙班治疗急性肺血栓栓塞疗效及对患者血生化指标、右心室功能的影响研究[J].陕西医学杂志,2020,49(7):874-877,880.
[24] 汪 瑞,袁 昕.补肺化瘀汤结合DP方案对晚期非小细胞肺癌患者T淋巴细胞和血清cyfra21-1及MK表达的影响[J].现代中西医结合杂志,2020,29(18):2013-2016.
[25] 冯 原,陈斯宁,江 颖,等.补肺化瘀汤辅助治疗非小细胞肺癌的临床疗效及其对血清一氧化氮和血管内皮生长因子水平的影响研究[J].中国全科医学,2019,22(18):2223-2229.
[26] 徐国亮.温心肾补肺涤痰化瘀汤配合西药治疗慢性肺源性心脏病急性加重期临床疗效观察[J].中国中医急症,2014,23(12):2315-2317.

备注/Memo

备注/Memo:
基金项目:武汉市卫生健康委员会临床医学科研基金资助项目(WX18D05)
更新日期/Last Update: 2021-12-09